Page 11 - Genomics & Genetics

As detailed in a separate post, bit.bio have developed a novel cellular reprogramming technology, opti-ox™¹ (optimized inducible overexpression), that can generate functional cells with high consistency

To overcome current cell model limitations, bit.bio have developed a new, innovative technology to reprogram human stem cells with precise control of transcription factor expression through iPSC engineering.

Every type of cell has different membrane properties, meaning that transfection of your specific nucleic acid can become challenging.

To overcome transfection limitations, RJH Biosciences have developed

Following on from the popular SiR-Probes, earlier this year Spirochrome introduced new SPY probes, as presented in this post.

Take a few minues to watch this video of the SPY™ Actin, Tubulin and DNA

Hyaluronic acid (also called HA or Hyaluronan) is a glycosaminoglycan with elevated viscosity, enabling tissues (eye, skin, joint and synovial fluid...) to resist to physical and mechanical constraints

Alone, or in combination with other therapies, Immuno-Oncology (I-O) appears currently as one of the most promising research fields to fight cancer. Nevertheless, developing breakthrough therapies to fully

Based on a novel variety of Magnetic Nanoparticles, ElementZero have just launched a unique technology, allowing specific capture and enrichment of a broad variety of viral RNA (SARS-CoV-2, HIV, Ebola

Researchers have shown that proteases are actively used by SARS-CoV-2 for it's entry and replication into human cells. To support research on this topic, tebu-bio provides a full range of screening kits

To better understand the mechanism of SARS-CoV-2 cell entry, BPS Bioscience have developed 3 new pseudotyped lentiviruses, allowing you to study the interaction between the coronavirus Spike protein and

One of the challenges in respiratory research in general, and for COVID-19 related projects in particular, is to have access to relevant in vitro cell culture models. Human lung epithelium models are currently

Advances in mRNA Vaccines for Infectious Diseases

It is now admitted that mRNA vaccines provide a safe and long-lasting immune response in humans. Since capping of the mRNA is involved in the protein production

mRNA vaccines are developing very quickly with dozens of ongoing clinical trials against cancers or infectious diseases (e.g. HIV or more recently SARS-Cov-2). Recombinant monoclonal antibody (mAB) based